<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0470">
 <label>94</label>
 <mixed-citation publication-type="other" id="or0055">Lopinavir/Ritonavir, Ribavirin and IFN-beta combination for nCoV treatment - full text view - 
  <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov" id="ir0455" xmlns:xlink="http://www.w3.org/1999/xlink">ClinicalTrials.gov</ext-link>, (n.d.). 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04276688" id="ir0460" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04276688</ext-link> (accessed April 9, 2020).
 </mixed-citation>
</ref>
